When testing for prostate cancer, multiparametric MRI with or without targeted biopsy was more effective than the common standard transrectal ultrasonography-guided biopsy, but a recently published editorial argues more testing is needed.

On May 8, the Journal of the American Medical Association released an update to the 2012 U.S. Preventive Services Task Force (USPSTF) recommendation regarding prostate-specific antigen (PSA)-based screening for prostate cancer.

3D breast ultrasound can measure a patient's tumor response after receiving neoadjuvant chemotherapy (NAC) better than a standard breast MRI, according to a study published in the European Journal of Radiology.

Triple assessment including radiological imaging is the best practice for younger patients showing low-risk breast related symptoms, according to a new study published in Clinical Radiology.

A team from Washington University in St. Louis developed a proof-of-concept technique to detect tumor biomarkers via a blood test using noninvasive focused ultrasound. The method could potentially eliminate surgical biopsies, according to a study in Scientific Reports.

Recent research found the chances of survival in patients with lung cancer significantly improves if they are given immunotherapy treatment along with chemotherapy, according to a study in the New England Journal of Medicine.

A new study led by researchers at the Perelman School of Medicine at the University of Pennsylvania found the longer patients with positive cancer screening results wait for diagnostic testing, the worse their outcome.

Contrast-enhanced subharmonic imaging (SHI)—a new technique for imaging of microbubble ultrasound contrast agents—detected prostate cancers not identified by traditional MRI, according to a recent study presented at the American Roentgen Ray Society (ARRS) 2018 Annual Meeting.